Company Filing History:
2 out of 3 
2 out of 6 Years Active: 2022-2025
Title: Hanns Lochmuller: Innovator in Gene Therapy
Introduction
Hanns Lochmuller is a prominent inventor based in Newcastle upon Tyne, GB. He has made significant contributions to the field of gene therapy, particularly in the treatment of muscular dystrophy. With a total of two patents to his name, Lochmuller is recognized for his innovative approaches to medical challenges.
Latest Patents
Lochmuller's latest patents focus on the use of adeno-associated virus (AAV) vectors for gene therapy. His inventions provide methods for delivering a functional fragment of the miniaturized human micro-dystrophin gene. This gene therapy aims to express the fragment of micro-dystrophin in skeletal muscles, including the diaphragm and cardiac muscle. The goal is to protect muscle fibers from injury, increase muscle strength, and reduce or prevent fibrosis in subjects suffering from muscular dystrophy.
Career Highlights
Throughout his career, Hanns Lochmuller has worked with esteemed institutions such as Newcastle University and the University of Heidelberg. His research has been pivotal in advancing the understanding and treatment of muscular dystrophy through innovative gene therapy techniques.
Collaborations
Lochmuller has collaborated with various professionals in his field, including his coworker Oliver Muller. These collaborations have further enhanced the impact of his research and inventions.
Conclusion
Hanns Lochmuller is a key figure in the realm of gene therapy, with a focus on muscular dystrophy treatment. His patents and collaborations reflect his commitment to advancing medical science and improving patient outcomes.